Capital Flow Monitor · Sponsors · CIK 1891891
Quanta Therapeutics, Inc.
TWO TOWER PLACE, FLOOR 17, SOUTH SAN FRANCISCO, CA, 94080 · (970) 742-4190
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$89.1M
Sold
$76.2M
% sold
85.5%
Investors
17
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-24 | D/A ·current | 506(b) | $89.1M | $76.2M | 85.5% | 17 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Perry Nisen — Executive Officer / Director, San Francisco, CA
-
Maria Fardis — Director, San Francisco, CA
1 other raise
- AirNexis Therapeutics, Inc. $62.0M of $200.0M · 31.0%
-
Rajul Jain — Director, San Francisco, CA
2 other raises
- Vida Ventures IV, L.P. $0 of $500.0M · 0.0%
- SonoThera, Inc. $125.5M of $125.5M · 100.0%
-
Ying Huang — Director, San Francisco, CA
1 other raise
- DEEPBLUE VALUE ADD FUND 2025 LLC $3.7M of $30.0M · 12.2%
- Derek Metzger — Executive Officer, San Francisco, CA
-
Maha Katabi — Director, San Francisco, CA
2 other raises
- Sofinnova Venture Partners XII, L.P. $527.1M of $550.0M · 95.8%
- Star Therapeutics LLC $125.0M of $125.0M · 100.0%
- Cameron Pitt — Executive Officer / Director, San Francisco, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.